Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.
Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the best US stocks to buy under $50. On January 12, Viking Therapeutics, ...
In Darwinian terms, survival isn’t a matter of being the biggest, the fastest, or the strongest of the species, but instead of adaptability.
GlobalData on MSN
FDA and EMA release collaborative AI framework for drug development
The joint guidance was created to ensure drug developers employ best practices when using AI.
FDA and EMA have issued 10 guiding principles for AI in drug development with the intended goal of ensuring safety and ...
HKeyBio, a preclinical CRO focused on autoimmune and allergic disease drug development, today announced a translational preclinical strategy, HKEY-AIRxTM1.0 designed to address one of the most persis ...
A new analysis of drug trials used to approve medicines in the United States shows how far modern medicine still has to go to ...
The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.
The San Diego firm took a step in that direction on Tuesday, when it unveiled what it says will be the world’s largest ...
Loyal’s application for drug approval is another step closer to potential approval through the FDA Center for Veterinary Medicine.
HKeyBio, a preclinical CRO focused on autoimmune and allergic disease drug development, announced HKEY-AIRx1.0, a translational preclinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results